All News
EULAR 2019 – Day 3 Report
The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day.
Read Article
This is a nice study but does not address effects on CRITICAL and PATHOGENIC autoantibody production- Prosepctive studies are urgently needed in SLE and AAV among others @GSKUS @Lupusdoc @LupusOrg @LupusResearch @RheumNow @HealioRheum @CCalabreseDO #shingles https://t.co/7yhHmQfphY
Leonard Calabrese LCalabreseDO ( View Tweet)
Sorry to have missed this critical session - but feeling better- Closing the gap between pateint and provider is the new horizon in well being as opposed to health All reports of #EULAR2019 are terrific and following on @RheumNow #empathy https://t.co/DUhlRMtrDX
Leonard Calabrese LCalabreseDO ( View Tweet)
Analysis from the BSRBR ankylosing spondylitis registry of 2420 AS pts shows that HLA-B27 is associated with an increased risk of anterior uveitis but a decreased risk of psoriasis and IBD. #Eular2019 OP0262 https://t.co/jslLYkMr9Q
Dr. John Cush RheumNow ( View Tweet)
Do you stop #methotrexate in your male patients who wish to conceive? No need to do so according to studies from the past few years: no increase in adverse pregnancy outcomes if paternal exposure. Prof. Monika Ostensen at #EULAR2019 >LA
ARD & RMD Open ARD_BMJ ( View Tweet)
Gr8. Tocilizumab in GCA - data we’ve been waiting to see RT @chechitap: #EULAR2019 giacta long term https://t.co/UEFX4fY3Nw
Dr Irwin Lim _connectedcare ( View Tweet)
Shingrix can be give to inflammatory arthritis pts? Collective report from the Brigham & Women’s Hospital looked at the safety of Shingrix given to 300 RA, PsA, etc patient without any reports of H.Zoster and a 4% rate of "flares". #EULAR2019 FRI0068 https://t.co/Wkx5V9vM8r https://t.co/kErMMU97tB
Links:
Dr. John Cush RheumNow ( View Tweet)
What’s next in biosimilars? Visit RheumNow to listen to experts discuss this and more in "Therapeutic Update: Biosimilars in Rheumatology," a video series sponsored by Sandoz, Inc. https://t.co/1vmnEJqOSi #sponsored #biosimilars
Links:
Dr. John Cush RheumNow ( View Tweet)
Very interesting. Another strike against steroids...? https://t.co/LGz7fKh9hU
Paul Sufka, MD psufka ( View Tweet)
Updated treatment algorithm for extrarenal #Lupus
👉🏻 MSK
👉🏻 Skin
👉🏻 Hematological
👉🏻 Cardiovascular
👉🏻 Lung
👉🏻Serositis
👉🏻 Vasculitis
#EULAR2019 https://t.co/LDr0hKZAfV
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
JAK system really important for many bodily functions. So the aim is to “turn down the thermostat” without “turning it off” Ernest Choy #EULAR2019 https://t.co/863ktP3CIg
Dr Irwin Lim _connectedcare ( View Tweet)
#EULAR2019 session ‘Getting A Grip on The Comorbidities in Gout’ focused on the complex and variable disease profile patients experience and clinicians treat. Do #gout co-morbidities occur in patterns? Dr Ed Roddy discusses. Abstract SP0061 @RheumNow https://t.co/EHoNdP7iMo
Gout Study Group GoutGroup ( View Tweet)
Baracitinib affects JAK2 more than Tofacitinib. Difference can be seen with lower Hb & higher platelets #EULAR2019 https://t.co/BfzuyZI8f9
Dr Irwin Lim _connectedcare ( View Tweet)
JAKi also helps reduce bone loss #EULAR2019 https://t.co/8JOUp3aJWQ
Dr Irwin Lim _connectedcare ( View Tweet)
This graph is a reminder that over time, the level of Inflammation in RA may reduce with lower symptoms. However, CUMULATIVE inflam leads to increasing damage & disability #EULAR2019 https://t.co/ujhODMOp4E
Dr Irwin Lim _connectedcare ( View Tweet)
Look at the difference in patient reported outcome measures. Baracitinib vs Adalimumab #EULAR2019 https://t.co/xrQDdKIspV
Dr Irwin Lim _connectedcare ( View Tweet)
Risk factors for #sarcopenia in #rheumatoid arthritis
👉🏼Male
👉🏼Old age
👉🏼Glucocorticoid
👉🏼Increased MMP3
👉🏼Increased HAQ
#EULAR2019 THU0159
#muscle #RheumatoidArthritis https://t.co/Fn1SvCapqm
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
patients are lucky to have docs like @DrHillaryNorton sharing these #arthritis #breakthroughs #EULAR2019 https://t.co/nQg1WIFD4c
CreakyJoints.org CreakyJoints ( View Tweet)
Optimizing
➡️#weight
➡️sleep
➡️physical #health
➡️emotional health
➡️MTX use
👉🏼may improve persistent #fatigue beyond control of #rheumatoid inflammation
via @Susanbartlett12 #EULAR2019
#obesity https://t.co/vuMNWazloo
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
TNF inhibitors vs JAK inhibitors: what’s the head-to-head study state of play?
(**efficacy not safety, non-real life data of course)
#EULAR2019 Gerd Burmester on ‘The wind of change in RA’ @RheumNow https://t.co/zK1wqskmLc
David Liew drdavidliew ( View Tweet)
